Stockholm, Sweden – Barnik Invest Group today announced an investment in CathPrint AB, a pioneering company developing innovative technologies for advanced catheter design.
CathPrint’s groundbreaking “e-shaft” technology revolutionizes catheter manufacturing by enabling the integration of electronics directly onto the catheter shaft. This innovative approach offers significant advantages over traditional methods, including enhanced functionality, improved patient outcomes, and reduced manufacturing costs.
“We are excited to partner with CathPrint and support their innovative approach to catheter technology,” said Hamid Bakhshi, CEO of Barnik Invest Group. “CathPrint’s technology has the potential to transform the field of interventional medicine by enabling the development of more sophisticated and effective catheters. This investment aligns perfectly with Barnik Invest’s mission to support cutting-edge companies that are driving innovation in healthcare.”
CathPrint’s mission is to empower healthcare providers with advanced catheter solutions that improve patient care. By enabling more sophisticated and cost-effective catheter designs, CathPrint aims to improve patient outcomes and enhance the accessibility of advanced medical procedures.
For more information, please contact;
Hamid Bakhshi, CEO
Telephone: +46738531165
E-mail: hamid.bakhshi@barnikinvest.com
About Barnik Invest Group
Barnik Invest Group is a leading 360 solution partner for small Life Science companies in the Nordics. The company provides a comprehensive suite of services to support its portfolio companies, including capital, clinical development, expertise, and commercialization. Through its fully-owned subsidiaries, Medicorent and StartUpPharma, Barnik Invest offers CRO services, outsourcing, recruitment, distribution, product development and commercialization solutions. Barnik’s mission is to nurture promising life science companies from early clinical development phase to commercialization, enabling them to achieve positive cash flows or successful exits and ultimately enhancing patient well-being and improving human health worldwide. For more information visit www.barnikinvest.com.
